Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of <scp> CD4 <sup>+</sup> </scp> T‐cells for the treatment of Hyper <scp>IgM1</scp>Daniele Canarutto, Luigi Naldini, Simona Porcellini et al.|The EMBO Journal|2023Cited by 10
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Alessia Potenza, Zulma Magnani et al.|Nature Communications|2026Cited by 2